A S Robb

Summary

Affiliation: Children's National Medical Center
Country: USA

Publications

  1. ncbi Case study. Risperidone-Induced neuroleptic malignant syndrome in an adolescent
    A S Robb
    Department of Psychiatry and Behavioral Science, The Children s National Medical Center, Washington, DC 20010, USA
    J Child Adolesc Psychopharmacol 10:327-30. 2000
  2. ncbi Managing irritability and aggression in autism spectrum disorders in children and adolescents
    Adelaide S Robb
    Department of Psychiatry and Pediatrics, George Washington University Medical Center, Children s National Medical Center, Washington, DC, USA
    Dev Disabil Res Rev 16:258-64. 2010
  3. ncbi Glycopyrrolate for treatment of clozapine-induced sialorrhea in three adolescents
    Adelaide S Robb
    Department of Psychiatry and Behavioral Sciences, Children s National Medical Center, 111 Michigan Avenue NW, Washington, D C, USA
    J Child Adolesc Psychopharmacol 18:99-107. 2008
  4. ncbi Sertraline treatment of children and adolescents with posttraumatic stress disorder: a double-blind, placebo-controlled trial
    Adelaide S Robb
    Department of Psychiatry and Behavioral Sciences, Children s National Medical Center, 111 Michigan Ave, N W, Washington, DC 20010, USA
    J Child Adolesc Psychopharmacol 20:463-71. 2010
  5. ncbi Supplemental nocturnal nasogastric refeeding for better short-term outcome in hospitalized adolescent girls with anorexia nervosa
    Adelaide S Robb
    Department of Psychiatry and Behavioral Sciences, Children s National Medical Center, Washington, DC 20010, USA
    Am J Psychiatry 159:1347-53. 2002
  6. ncbi Eating disorders in males
    Adelaide S Robb
    Department of Psychiatry and Behavioral Sciences, Children s National Medical Center, 111 Michigan Avenue Northwest, Washington, DC 20010 2970, USA
    Child Adolesc Psychiatr Clin N Am 11:399-418, xi. 2002
  7. ncbi Eating disorders in children. Diagnosis and age-specific treatment
    A S Robb
    Department of Child and Adolescent Psychiatry and Pediatrics, Children s National Medical Center, Washington, DC, USA
    Psychiatr Clin North Am 24:259-70. 2001
  8. ncbi Eating disorders and health insurance understanding and overcoming obstacles to treatment
    Tomas J Silber
    Department of General Pediatrics and Adolescent Medicine, Children s National Medical Center, George Washington University School of Medicine and Health Sciences, Washington, DC, USA
    Child Adolesc Psychiatr Clin N Am 11:419-28, xii. 2002
  9. ncbi Nocturnal nasogastric refeeding for hospitalized adolescent boys with anorexia nervosa
    Tomas J Silber
    Division of Adolescent Medicine, Children s National Medical Center, Washington DC 20010, USA
    J Dev Behav Pediatr 25:415-8. 2004
  10. ncbi Changes in positive and negative syndrome scale-derived hostility factor in adolescents with schizophrenia treated with aripiprazole: post hoc analysis of randomized clinical trial data
    Adelaide S Robb
    Children s National Medical Center, Washington, DC 20010 2970, USA
    J Child Adolesc Psychopharmacol 20:33-8. 2010

Detail Information

Publications11

  1. ncbi Case study. Risperidone-Induced neuroleptic malignant syndrome in an adolescent
    A S Robb
    Department of Psychiatry and Behavioral Science, The Children s National Medical Center, Washington, DC 20010, USA
    J Child Adolesc Psychopharmacol 10:327-30. 2000
    ..This article presents a risperidone-induced case in the youngest patient to date, raising issues concerning our perceptions, the safety of newer neuroleptics, and treatment of NMS...
  2. ncbi Managing irritability and aggression in autism spectrum disorders in children and adolescents
    Adelaide S Robb
    Department of Psychiatry and Pediatrics, George Washington University Medical Center, Children s National Medical Center, Washington, DC, USA
    Dev Disabil Res Rev 16:258-64. 2010
    ..Medications to treat the irritability will be discussed across categories of antipsychotics, antidepressants, antihypertensive agents, and others. Emphasis will be placed on medications with the most safety and efficacy and FDA approval...
  3. ncbi Glycopyrrolate for treatment of clozapine-induced sialorrhea in three adolescents
    Adelaide S Robb
    Department of Psychiatry and Behavioral Sciences, Children s National Medical Center, 111 Michigan Avenue NW, Washington, D C, USA
    J Child Adolesc Psychopharmacol 18:99-107. 2008
    ..The aim of this case study was to report preliminary data on the effectiveness and tolerability of glycopyrrolate for the treatment of clozapine-induced sialorrhea, or excessive flow of saliva, in an adolescent population...
  4. ncbi Sertraline treatment of children and adolescents with posttraumatic stress disorder: a double-blind, placebo-controlled trial
    Adelaide S Robb
    Department of Psychiatry and Behavioral Sciences, Children s National Medical Center, 111 Michigan Ave, N W, Washington, DC 20010, USA
    J Child Adolesc Psychopharmacol 20:463-71. 2010
    ..The aim of this study was to evaluate the safety and efficacy of sertraline in children and adolescents who met Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) criteria for posttraumatic stress disorder (PTSD)...
  5. ncbi Supplemental nocturnal nasogastric refeeding for better short-term outcome in hospitalized adolescent girls with anorexia nervosa
    Adelaide S Robb
    Department of Psychiatry and Behavioral Sciences, Children s National Medical Center, Washington, DC 20010, USA
    Am J Psychiatry 159:1347-53. 2002
    ..This study compared the short-term outcomes of standard oral refeeding and supplemental nocturnal nasogastric refeeding...
  6. ncbi Eating disorders in males
    Adelaide S Robb
    Department of Psychiatry and Behavioral Sciences, Children s National Medical Center, 111 Michigan Avenue Northwest, Washington, DC 20010 2970, USA
    Child Adolesc Psychiatr Clin N Am 11:399-418, xi. 2002
    ..This article reviews subgroups of boys who are at higher risk for developing eating disorders. The article commences with the difference in male perceptions of body image and dieting behaviors...
  7. ncbi Eating disorders in children. Diagnosis and age-specific treatment
    A S Robb
    Department of Child and Adolescent Psychiatry and Pediatrics, Children s National Medical Center, Washington, DC, USA
    Psychiatr Clin North Am 24:259-70. 2001
    ..With appropriate evaluation and treatment, eating disorders can be stopped in childhood...
  8. ncbi Eating disorders and health insurance understanding and overcoming obstacles to treatment
    Tomas J Silber
    Department of General Pediatrics and Adolescent Medicine, Children s National Medical Center, George Washington University School of Medicine and Health Sciences, Washington, DC, USA
    Child Adolesc Psychiatr Clin N Am 11:419-28, xii. 2002
    ....
  9. ncbi Nocturnal nasogastric refeeding for hospitalized adolescent boys with anorexia nervosa
    Tomas J Silber
    Division of Adolescent Medicine, Children s National Medical Center, Washington DC 20010, USA
    J Dev Behav Pediatr 25:415-8. 2004
    ..Their average length of hospitalization was also shorter. Nocturnal nasogastric refeeding, complementing oral refeeding, should be considered as an alternative initial therapy for weight restoration in males with anorexia nervosa...
  10. ncbi Changes in positive and negative syndrome scale-derived hostility factor in adolescents with schizophrenia treated with aripiprazole: post hoc analysis of randomized clinical trial data
    Adelaide S Robb
    Children s National Medical Center, Washington, DC 20010 2970, USA
    J Child Adolesc Psychopharmacol 20:33-8. 2010
    ..This post hoc analysis evaluated the effects of aripiprazole on Positive and Negative Syndrome Scale (PANSS) Hostility factor scores in adolescents with schizophrenia...
  11. ncbi A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder
    Mark A Stein
    Department of Psychiatry, University of Chicago, Chicago, Illinois 60637, USA
    Pediatrics 112:e404. 2003
    ..This study was conducted to examine dosage effects on ADHD symptoms and stimulant side effects and to explore potential moderating effects of ADHD subtype...